BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38839658)

  • 1. Laboratory features and pharmacological management of early and late-onset primary Sjögren's syndrome.
    Saleem RA; Ramadan M; Elshaaer Y; Sukkarieh H; Alissa R; Alhusseini N; Tamim H; Alshahrani A; Almaimoni H
    Rheumatol Int; 2024 Jul; 44(7):1317-1325. PubMed ID: 38839658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
    Fox RI; Dixon R; Guarrasi V; Krubel S
    Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis.
    Wang SQ; Zhang LW; Wei P; Hua H
    BMC Musculoskelet Disord; 2017 May; 18(1):186. PubMed ID: 28499370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum ICAM-1, VCAM-1 and E-selectin levels in patients with primary and secondary Sjögren's syndrome.
    Błochowiak KJ; Olewicz-Gawlik A; Trzybulska D; Nowak-Gabryel M; Kocięcki J; Witmanowski H; Sokalski J
    Adv Clin Exp Med; 2017 Aug; 26(5):835-842. PubMed ID: 29068581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
    Demarchi J; Papasidero S; Medina MA; Klajn D; Chaparro Del Moral R; Rillo O; Martiré V; Crespo G; Secco A; Catalan Pellet A; Amitrano C; Crow C; Asnal C; Pucci P; Caeiro F; Benzanquen N; Pirola JP; Mayer M; Zazzetti F; Velez S; Barreira J; Tamborenea N; Santiago L; Raiti L
    Clin Rheumatol; 2017 Nov; 36(11):2455-2460. PubMed ID: 28913747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
    Goules AV; Argyropoulou OD; Pezoulas VC; Chatzis L; Critselis E; Gandolfo S; Ferro F; Binutti M; Donati V; Zandonella Callegher S; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos T; Mavragani CP; Baldini C; Skopouli FN; Fotiadis DI; De Vita S; Moutsopoulos HM; Tzioufas AG
    Front Immunol; 2020; 11():594096. PubMed ID: 33193443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Sjögren's syndrome in children and adolescents: proposal for diagnostic criteria.
    Bartůnková J; Sedivá A; Vencovský J; Tesar V
    Clin Exp Rheumatol; 1999; 17(3):381-6. PubMed ID: 10410277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal tubular acidosis and associated factors in patients with primary Sjögren's syndrome: a registry-based study.
    Zhang Y; Qiao L; Zhang L; Li Q; Yang P; Kong X; Duan X; Zhang M; Li X; Wang Y; Xu J; Wang Y; Hsieh E; Zhao J; Xu D; Li M; Zhao Y; Zeng X
    Clin Rheumatol; 2023 Feb; 42(2):431-441. PubMed ID: 36383239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased CD200 levels in peripheral blood mononuclear cells of patients with primary Sjögren's syndrome.
    Liu TT; Zeng XP; Gu ML; Deng AM
    Int J Rheum Dis; 2020 May; 23(5):654-660. PubMed ID: 32180363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.
    Cornec D; Devauchelle-Pensec V; Mariette X; Jousse-Joulin S; Berthelot JM; Perdriger A; Puéchal X; Le Guern V; Sibilia J; Gottenberg JE; Chiche L; Hachulla E; Hatron PY; Goeb V; Hayem G; Morel J; Zarnitsky C; Dubost JJ; Seror R; Pers JO; Meiners PM; Vissink A; Bootsma H; Nowak E; Saraux A
    Rheumatology (Oxford); 2015 Sep; 54(9):1699-708. PubMed ID: 25957440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated serum lipid profile is associated with inflammation and disease activity in primary Sjögren's syndrome: a retrospective study in China.
    Yang L; Liang Y; Pu J; Cai L; Gao R; Han F; Chang K; Pan S; Wu Z; Zhang Y; Wang Y; Song J; Wu H; Tang J; Wang X
    Immunol Lett; 2024 Jun; 267():106865. PubMed ID: 38705483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D in "early" primary Sjögren's syndrome: does it play a role in influencing disease phenotypes?
    Baldini C; Delle Sedie A; Luciano N; Pepe P; Ferro F; Talarico R; Tani C; Mosca M
    Rheumatol Int; 2014 Aug; 34(8):1159-64. PubMed ID: 24097207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
    ter Borg EJ; Kelder JC
    Clin Rheumatol; 2016 Mar; 35(3):649-55. PubMed ID: 26791875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
    Liang Y; Xian Z; Fu D; Liu S; Yao Y; Jin Y; Gao C; Shen L; Shi G; He J
    Front Immunol; 2021; 12():673658. PubMed ID: 34012457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile onset of primary Sjögren's syndrome: report of 10 cases.
    Ostuni PA; Ianniello A; Sfriso P; Mazzola G; Andretta M; Gambari PF
    Clin Exp Rheumatol; 1996; 14(6):689-93. PubMed ID: 8978969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Sjögren's-syndrome-related antigen A autoantibodies (Anti-SSA antibody) and meningoencephalitis: Sjögren's syndrome waiting to be unveiled? A case series and review of literature.
    Mittal GK; Mittal S; Kaur H; Stephen SR; Sekhar S; Sureshbabu S; Sandhya P
    Rheumatol Int; 2021 Oct; 41(10):1855-1866. PubMed ID: 33040168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Sjögren's syndrome.
    Bowman SJ
    Lupus; 2018 Oct; 27(1_suppl):32-35. PubMed ID: 30452329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical and laboratory characteristics of Sjögren's syndrome that progresses to systemic lupus erythematosus: a retrospective case-control study.
    Yang Y; Li Z; Wang L; Zhang F
    Int J Rheum Dis; 2013 Apr; 16(2):173-7. PubMed ID: 23773641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of patients with primary Sjögren's syndrome associated interstitial lung disease and relevant features of disease progression.
    Zhang T; Yuan F; Xu L; Sun W; Liu L; Xue J
    Clin Rheumatol; 2020 May; 39(5):1561-1568. PubMed ID: 31902032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.